COVID-19 has an important multiorgan effect, and because of its physiopathology and relationship to ACE2, it causes renal illness and vascular effects, which induce hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, and eclampsia), hepatic injury, and other conditions. In terms of hematological manifestations, thrombocytopenia has a prevalence of approximately 5% to 40% in patients with this particular infection. Here, ACE2 is linked to COVID-19.